Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 897.40
-2.55 (-0.28%)
Oct 31, 2025, 3:29 PM IST
Alembic Pharmaceuticals Employees
Alembic Pharmaceuticals had 16,571 employees as of March 31, 2025. The number of employees increased by 1,713 or 11.53% compared to the previous year.
Employees
16,571
Change (1Y)
1,713
Growth (1Y)
11.53%
Revenue / Employee
4.12M INR
Profits / Employee
363.94K INR
Market Cap
176.40B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 16,571 | 1,713 | 11.53% |
| Mar 31, 2024 | 14,858 | 265 | 1.82% |
| Mar 31, 2023 | 14,593 | 2,377 | 19.46% |
| Mar 31, 2022 | 12,216 | 56 | 0.46% |
| Mar 31, 2021 | 12,160 | 584 | 5.04% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Glenmark Pharmaceuticals | 15,800 |
Alembic Pharmaceuticals News
- 7 weeks ago - Alembic Pharma receives USFDA final approval for Phytonadione Injectable Emulsion USP - Business Upturn
- 2 months ago - Alembic Pharma gains as USFDA approves Macitentan tablets for pulmonary arterial hypertension - Business Upturn
- 2 months ago - Alembic Pharma shares jump over 2% as USFDA approves Tretinoin Cream USP - Business Upturn
- 2 months ago - Top stocks to watch today, August 18: JK Cement, Swiggy, KEC International, Alembic Pharmaceuticals, Glenmark, auto stocks and more - Business Upturn
- 2 months ago - Stocks to watch today, August 18: Alembic Pharma, EMS, JK Cement, Star Cement, HDFC Bank, Vodafone Idea, Inox Wind and more - Business Upturn
- 3 months ago - Alembic Pharma share: Antique maintains buy, raises target to Rs 1,275 on US growth outlook - Business Upturn
- 3 months ago - Alembic Pharma gets USFDA nod for Carbamazepine Extended-Release Tablets - Business Upturn
- 4 months ago - Alembic Pharma acquires UK-based Utility Therapeutics for $12 million to expand US presence - Business Upturn